Top Markets
#1 Black Phoenix Black Phoenix +826.24%
#2 pipedog pipedog +31.68%
#3 SAFEcoin SAFEcoin +25.89%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.03%
#5 Beam Beam +23.05%
#6 PondCoin PondCoin +22.94%
#7 Bless Bless +22.38%
#8 Magma Finance Magma Finance +19.68%
#9 Prom Prom +16.39%
#10 YFSX YFSX +15.97%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Rangering i aksjer #6243
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Aksjekurs
$29.15
Markedsverdi
$2.14B
Endring (1 dag)
-0.53%
Endring (1 år)
95.24%
Land
US
Handel Zymeworks Inc. (ZYME)

Kategori

Healthcare
Aksjeprishistorikk for Zymeworks Inc. (ZYME)
Høyeste sluttskurs: $26.22 den 2026-08-01

Laveste sluttskurs: $13.00 den 2017-04-01
Aksjeprishistorikk for Zymeworks Inc. fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -12.16%
2025 90.41%
2024 44.87%
2023 30.92%
2022 -56.92%
2021 -67.45%
2020 19.67%
2019 233.57%
2018 63.85%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 40.94%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.46%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 461.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH